Media Center

Welcome to the OSI Pharmaceuticals Media Center. This Newsroom is designed to provide journalists with easy access to OSI news and other information.

Latest News

01/28/2010
Novella Clinical and OSI Pharmaceuticals Expand Clinical Services Agreement

01/15/2010
FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer

View more news

Fact Sheets and Brochures

Media Contacts

If you are a member of the media, please call our Corporate Relations department:

 
Kathy Galante
Senior Director, Investor and Public Relations
Phone: 631-962-2043
Email: kgalante@osip.com
Kim Wittig
Director, Public Relations
Phone: 631-962-2135
Email: kwittig@osip.com